|
|
||||||||
Departments of Internal Medicine and Surgery and the Cardiovascular Center, University of Iowa College of Medicine and Veterans Affairs Medical Center, Iowa City, Iowa 52246
In the canine coronary microcirculation,
acetylcholine (ACh)-induced vasodilation of large (
100 µm)
epicardial arterioles (LgA), but not small (<100 µm) epicardial
arterioles (SmA), is blocked by nitric oxide (NO) synthase inhibitors
in vivo. We hypothesized that the ACh-induced vasodilation of SmA is
mediated by a cytochrome P-450
metabolite of arachidonic acid (AA). Epicardial coronary microvascular
diameters in dogs were measured at baseline and after treatment with
topically applied ACh (1, 10, and 100 µM), AA (1, 5, and 10 µM), or
sodium nitroprusside (SNP; 10-100 µM). Coronary microvascular
diameters were compared among control dogs (group
OO); dogs pretreated with
N
-nitro-L-arginine
(L-NNA; 70 µM
topically) (group NO); dogs pretreated with
L-NNA plus clotrimazole (Clo;
1.6 µM topically) or 17-octadecynoic acid (ODYA; 2 µM topically),
cytochrome P-450 monooxygenase
inhibitors (groups NC and
NY, respectively); dogs pretreated
with Clo alone (group OC); and dogs
pretreated with L-NNA plus Clo
with AA as the agonist (group AA).
ACh-induced vasodilation of LgA was abolished by
L-NNA alone, whereas in SmA,
L-NNA was without effect. Clo alone did not inhibit ACh-induced dilation in either SmA or LgA. However, the combinations of
L-NNA plus either Clo or ODYA
abolished ACh- and AA-induced dilation of SmA (100 µM ACh: NC, 3 ± 5%; NY, 8 ± 2%; 10 µM AA: 6 ± 3%) but did not affect
responses to SNP. These results suggest that the ACh-induced
vasodilation of SmA is mediated in part by cytochrome
P-450 metabolites of AA and provide
the first evidence that the cytochrome
P-450 pathway contributes to the
regulation of coronary resistance vessels in vivo.
arachidonic acid; arginine analog; endothelium-derived hyperpolarizing factor; clotrimazole; intravital microscopy
This article has been cited by other articles:
![]() |
P. A. Dabisch, J. T. Liles, S. R. Baber, N. H. Golwala, S. N. Murthy, and P. J. Kadowitz Analysis of L-NAME-dependent and -resistant responses to acetylcholine in the rat Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H688 - H698. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Tune, M. W. Gorman, and E. O. Feigl Matching coronary blood flow to myocardial oxygen consumption J Appl Physiol, July 1, 2004; 97(1): 404 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tanaka, H. Kanatsuka, B.-H. Ong, T. Tanikawa, A. Uruno, T. Komaru, R. Koshida, and K. Shirato Cytochrome P-450 metabolites but not NO, PGI2, and H2O2 contribute to ACh-induced hyperpolarization of pressurized canine coronary microvessels Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1939 - H1948. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.L. Huang, D. El Kebir, A.S. De Buys Roessingh, J.C. Schneider, L. Jacob, J.C. Mercier, J. Dall'Ava-Santucci, and A.T. Dinh-Xuan Role of tyrosine phosphatase in the modulation of pulmonary vascular tone Eur. Respir. J., March 1, 2002; 19(3): 525 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-F. Wang, Y. Yang, M. F. Sullivan, J. Min, J. Cai, D. C. Zeldin, Y.-F. Xiao, and J. P. Morgan Induction of Cardiac Cytochrome P450 in Cocaine-Treated Mice Experimental Biology and Medicine, March 1, 2002; 227(3): 182 - 188. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Roman P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function Physiol Rev, January 1, 2002; 82(1): 131 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Campbell and D. R. Harder Prologue: EDHF-what is it? Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2413 - H2416. [Full Text] [PDF] |
||||
![]() |
P. Coats, F. Johnston, J. MacDonald, J. J. V. McMurray, and C. Hillier Endothelium-Derived Hyperpolarizing Factor : Identification and Mechanisms of Action in Human Subcutaneous Resistance Arteries Circulation, March 27, 2001; 103(12): 1702 - 1708. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Zink, C. L. Oltman, T. Lu, P. V. G. Katakam, T. L. Kaduce, H.-C. Lee, K. C. Dellsperger, A. A. Spector, P. R. Myers, and N. L. Weintraub 12-Lipoxygenase in porcine coronary microcirculation: implications for coronary vasoregulation Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H693 - H704. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nishikawa, D. W. Stepp, and W. M. Chilian Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H459 - H465. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nishikawa, D. W. Stepp, and W. M. Chilian In vivo location and mechanism of EDHF-mediated vasodilation in canine coronary microcirculation Am J Physiol Heart Circ Physiol, September 1, 1999; 277(3): H1252 - H1259. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. de Wit, N. Esser, H.-A. Lehr, S.-S. Bolz, and U. Pohl Pentobarbital-sensitive EDHF comediates ACh-induced arteriolar dilation in the hamster microcirculation Am J Physiol Heart Circ Physiol, May 1, 1999; 276(5): H1527 - H1534. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Campbell, C. Deeter, K. M. Gauthier, R. H. Ingraham, J. R. Falck, and P.-L. Li 14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of KCa channels Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1656 - H1664. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |